Fleury S/A Ord | Balance Sheet

Fiscal year is January-December. All values BRL Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
540
505
630
407
672
809
Total Accounts Receivable
485
492
472
478
565
586
Inventories
17
14
16
32
22
27
Other Current Assets
13
7
14
17
8
12
Total Current Assets
1,055
1,017
1,132
933
1,267
1,434
Net Property, Plant & Equipment
455
458
443
470
642
783
Total Investments and Advances
21
39
50
51
59
53
Long-Term Note Receivable
-
-
31
11
13
8
Intangible Assets
1,534
1,533
1,514
1,524
1,537
1,629
Other Assets
27
30
34
16
10
3
Total Assets
3,211
3,210
3,339
3,137
3,637
3,910
ST Debt & Current Portion LT Debt
73
78
188
148
316
Accounts Payable
104
105
105
143
148
Income Tax Payable
24
24
25
24
31
Other Current Liabilities
59
58
100
94
144
Total Current Liabilities
260
265
418
409
639
Long-Term Debt
911
961
802
684
746
Provision for Risks & Charges
18
20
34
34
30
Deferred Taxes
134
192
241
290
363
Other Liabilities
80
67
55
53
42
Total Liabilities
1,522
1,637
1,683
1,601
1,931
Common Equity (Total)
1,689
1,573
1,655
1,536
1,707
Total Shareholders' Equity
1,689
1,573
1,655
1,536
1,707
Total Equity
1,689
1,573
1,655
1,536
1,707
Liabilities & Shareholders' Equity
3,211
3,210
3,339
3,137
3,637

About Fleury

View Profile
Address
Avenida General Valdomiro de Lima
São Paulo Sao Paulo 04344
Brazil
Employees -
Website http://www.fleury.com.br
Updated 07/08/2019
Fleury SA engages in the provision of medical diagnostic services. Its brands include Fleury, Weinmann, Clínica, Felippe Mattoso a+, Labs a+, Diagnoson a+, and Serdil. The company operates through the following business segments: Diagnostic Medicine, Integrated Medicine, and Dental.